Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Randomized Trial to Evaluate the Prognostic Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy (Predict-Study)

NCT04269512 is registered in ClinicalTrials.gov with Martini-Klinik am UKE GmbH as lead sponsor.

NCT NCT04269512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Randomized Trial to Evaluate the Prognostic Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy (Predict-Study)
Lead sponsor
Martini-Klinik am UKE GmbH
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 15, 2019
Completion date
December 31, 2029
Enrollment
3,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer